238 related articles for article (PubMed ID: 26691054)
1. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation.
Zhao M; Fan J; Liu Y; Yu Y; Xu J; Wen Q; Zhang J; Fu S; Wang B; Xiang L; Feng J; Wu J; Yang L
Int J Oncol; 2016 Feb; 48(2):756-64. PubMed ID: 26691054
[TBL] [Abstract][Full Text] [Related]
2. TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells.
Peña-Rico MA; Calvo-Vidal MN; Villalonga-Planells R; Martínez-Soler F; Giménez-Bonafé P; Navarro-Sabaté À; Tortosa A; Bartrons R; Manzano A
Radiother Oncol; 2011 Oct; 101(1):132-9. PubMed ID: 21864926
[TBL] [Abstract][Full Text] [Related]
3. ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.
Sinha S; Ghildiyal R; Mehta VS; Sen E
Cell Death Dis; 2013 May; 4(5):e615. PubMed ID: 23640457
[TBL] [Abstract][Full Text] [Related]
4. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
Bensaad K; Tsuruta A; Selak MA; Vidal MN; Nakano K; Bartrons R; Gottlieb E; Vousden KH
Cell; 2006 Jul; 126(1):107-20. PubMed ID: 16839880
[TBL] [Abstract][Full Text] [Related]
5.
Wong EY; Wong SC; Chan CM; Lam EK; Ho LY; Lau CP; Au TC; Chan AK; Tsang CM; Tsao SW; Lui VW; Chan AT
Oncol Lett; 2015 Feb; 9(2):569-574. PubMed ID: 25621025
[TBL] [Abstract][Full Text] [Related]
6. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
Qian S; Li J; Hong M; Zhu Y; Zhao H; Xie Y; Huang J; Lian Y; Li Y; Wang S; Mao J; Chen Y
J Hematol Oncol; 2016 Nov; 9(1):128. PubMed ID: 27884166
[TBL] [Abstract][Full Text] [Related]
7. Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway.
Xie Y; Li Y; Peng X; Henderson F; Deng L; Chen N
Oral Oncol; 2013 Dec; 49(12):1113-20. PubMed ID: 24075781
[TBL] [Abstract][Full Text] [Related]
8. An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation.
Lui VW; Lau CP; Cheung CS; Ho K; Ng MH; Cheng SH; Hong B; Tsao SW; Tsang CM; Lei KI; Yamasaki Y; Mita A; Chan AT
Biochem Pharmacol; 2010 Jun; 79(12):1772-80. PubMed ID: 20219441
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells.
Xu X; Liu Y; Su J; Li D; Hu J; Huang Q; Lu M; Liu X; Ren J; Chen W; Sun L
Oncol Rep; 2016 Feb; 35(2):923-31. PubMed ID: 26573774
[TBL] [Abstract][Full Text] [Related]
10. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
Wanka C; Steinbach JP; Rieger J
J Biol Chem; 2012 Sep; 287(40):33436-46. PubMed ID: 22887998
[TBL] [Abstract][Full Text] [Related]
11. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
[TBL] [Abstract][Full Text] [Related]
12. Impact of TP53-induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma.
Toshida K; Itoh S; Iseda N; Izumi T; Yoshiya S; Toshima T; Ninomiya M; Iwasaki T; Oda Y; Yoshizumi T
Cancer Sci; 2024 Jan; 115(1):170-183. PubMed ID: 37878531
[TBL] [Abstract][Full Text] [Related]
13. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
14. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
15. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
[TBL] [Abstract][Full Text] [Related]
16. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
Sun FR; Wang SL; Wang M; Sun LM
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
[TBL] [Abstract][Full Text] [Related]
18. Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients.
Al-Khayal K; Abdulla M; Al-Obeed O; Al Kattan W; Zubaidi A; Vaali-Mohammed MA; Alsheikh A; Ahmad R
Oncol Rep; 2016 Mar; 35(3):1281-6. PubMed ID: 26675982
[TBL] [Abstract][Full Text] [Related]
19. The fructose-2,6-bisphosphatase TIGAR suppresses NF-κB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC.
Tang Y; Kwon H; Neel BA; Kasher-Meron M; Pessin JB; Yamada E; Pessin JE
J Biol Chem; 2018 May; 293(20):7578-7591. PubMed ID: 29650758
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor BLU promotes TRAIL-induced apoptosis by downregulating NF-κB signaling in nasopharyngeal carcinoma.
Zhou J; Huang Z; Wang Z; Liu S; Grandien A; Ernberg I; He Z; Zhang X
Oncotarget; 2017 Jul; 8(27):43853-43865. PubMed ID: 28029652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]